---
schema_version: "secwatch.filing_event.v1"
accession: "0001023024-25-000099"
form_type: "8-K"
ticker: "ANIP"
cik: "0001023024"
company_name: "ANI PHARMACEUTICALS INC"
filed_at: "2025-09-26T23:59:59+00:00"
generated_at: "2026-05-17T05:31:18.789996+00:00"
event_type: "other_material"
sentiment: "positive"
materiality_score: 0.5
calibrated_materiality_score: 0.5
confidence: "high"
source: SEC EDGAR
---

# ANI converts all Series A preferred to common; 602,900 shares issued, preferred eliminated

## Summary
- On Sep 26, 2025, ANI mandatorily converted 20,000 preferred shares into 482,320 common shares at $41.4662/share.
- On Aug 14, 2025, Ampersand converted 5,000 preferred shares into 120,580 common shares at the same price.
- All 25,000 preferred shares converted into 602,900 common shares; no preferred shares remain outstanding.
- Mandatory conversion triggered because 20-day VWAP exceeded 170% of conversion price ($70.50) after second anniversary.

## SEC filing metadata
- accession: 0001023024-25-000099
- form_type: 8-K
- ticker: ANIP
- cik: 0001023024
- company_name: ANI PHARMACEUTICALS INC
- filed_at: 2025-09-26T23:59:59+00:00
- event_type: other_material
- sentiment: positive
- materiality_score: 0.5
- calibrated_materiality_score: 0.5
- confidence: high
- sec_items: 3.02, 3.03
- EDGAR index: https://www.sec.gov/Archives/edgar/data/1023024/000102302425000099/0001023024-25-000099-index.htm
- EDGAR primary document: https://www.sec.gov/Archives/edgar/data/1023024/000102302425000099/ani-20250926.htm

## Machine-readable alternates
- HTML: https://secwatch.observer/filing/0001023024-25-000099
- JSON: https://secwatch.observer/filing/0001023024-25-000099.json
- Plain text: https://secwatch.observer/filing/0001023024-25-000099.txt

This AI-assisted summary is a reading aid. Review the linked SEC EDGAR filing before relying on any specific claim.